Altos Labs comes out of stealth with $3 billion of capital
Genetic Engineering & Biotechnology News (GEN) - 19-Jan-2022Huge backing that cellular reprogramming can have a significant impact on health and ageing
Join the club for FREE to access the whole archive and other member benefits.
Chief Scientist and Founder at Altos Labs
Dr. Klausner is currently Founder, Chief Scientist and Board Co-Chairman of Altos Labs. He is also founder and Chairman of Lyell Immunopharma, Inc. He was founder and Director of Juno Therapeutics and founder and Director of GRAIL. He is Chairman of Sonoma Therapeutics. Co-Founder and Chairman of Lifemine Therapeutics. He is the former Senior Vice President, Chief Medical Officer and Chief Opportunity Officer of Illumina Corporation. Previously, he was Executive Director for Global Health of the Bill and Melinda Gates Foundation. Dr. Klausner was appointed by President Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development as well as a past president of the American Society of Clinical Investigation. He has served in senior advisory roles to the US, Norwegian, Qatari and Indian governments.
Visit website: https://altoslabs.com/team/executive-leadership/rick-klausner/
See also: Altos Labs - Biotechnology company focused on cellular rejuvenation programming
Details last updated 21-Jan-2022
Huge backing that cellular reprogramming can have a significant impact on health and ageing